{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:52:52Z","timestamp":1794657172159,"version":"4.9.1"},"reference-count":48,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,6,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Apoptosis in megakaryocytes results in the formation of platelets. The role of apoptotic pathways in platelet turnover and in the apoptotic-like changes seen after platelet activation is poorly understood. ABT-263 (Navitoclax), a specific inhibitor of antiapoptotic BCL2 proteins, which is currently being evaluated in clinical trials for the treatment of leukemia and other malignancies, induces a dose-limiting thrombocytopenia. In this study, the relationship between BCL2\/BCL-XL inhibition, apoptosis, and platelet activation was investigated. Exposure to ABT-263 induced apoptosis but repressed platelet activation by physiologic agonists. Notably, ABT-263 induced an immediate calcium response in platelets and the depletion of intracellular calcium stores, indicating that on BCL2\/BCL-XL inhibition platelet activation is abrogated because of a diminished calcium signaling. By comparing the effects of ABT-263 and its analog ABT-737 on platelets and leukemia cells from the same donor, we show, for the first time, that these BCL2\/BCL-XL inhibitors do not offer any selective toxicity but induce apoptosis at similar concentrations in leukemia cells and platelets. However, reticulated platelets are less sensitive to apoptosis, supporting the hypothesis that treatment with ABT-263 induces a selective loss of older platelets and providing an explanation for the transient thrombocytopenia observed on ABT-263 treatment.<\/jats:p>","DOI":"10.1182\/blood-2011-03-344812","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T00:49:08Z","timestamp":1305161348000},"page":"7145-7154","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":178,"title":["BCL2\/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation"],"prefix":"10.1182","volume":"117","author":[{"given":"Meike","family":"Vogler","sequence":"first","affiliation":[{"name":"Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A.","family":"Hamali","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester and NIHR Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Sun","sequence":"additional","affiliation":[{"name":"Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T. W.","family":"Bampton","sequence":"additional","affiliation":[{"name":"Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dinsdale","sequence":"additional","affiliation":[{"name":"Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger T.","family":"Snowden","sequence":"additional","affiliation":[{"name":"Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J. S.","family":"Dyer","sequence":"additional","affiliation":[{"name":"Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison H.","family":"Goodall","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester and NIHR Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald M.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111815040899700_B1","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1182\/blood.V90.6.2234.2234_2234_2243","article-title":"In vitro senescence and apoptotic cell death of human megakaryocytes.","volume":"90","author":"Zauli","year":"1997","journal-title":"Blood"},{"issue":"6","key":"2019111815040899700_B2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ceb.2003.10.004","article-title":"Bcl-2-family proteins and the role of mitochondria in apoptosis.","volume":"15","author":"Kuwana","year":"2003","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"2019111815040899700_B3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death.","volume":"9","author":"Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2019111815040899700_B4","doi-asserted-by":"crossref","first-page":"C941","DOI":"10.1152\/ajpcell.00612.2008","article-title":"Bcl-2 family on guard at the ER.","volume":"296","author":"Szegezdi","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"2019111815040899700_B5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.physiol.70.021507.105852","article-title":"Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis.","volume":"70","author":"Rong","year":"2008","journal-title":"Annu Rev Physiol"},{"issue":"12","key":"2019111815040899700_B6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nrd2658","article-title":"BCL-2 family antagonists for cancer therapy.","volume":"7","author":"Lessene","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2019111815040899700_B7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/cdd.2008.137","article-title":"Bcl-2 inhibitors: small molecules with a big impact on cancer therapy.","volume":"16","author":"Vogler","year":"2009","journal-title":"Cell Death Differ"},{"key":"2019111815040899700_B8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours.","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"issue":"21","key":"2019111815040899700_B9","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1021\/jm800669s","article-title":"Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins.","volume":"51","author":"Park","year":"2008","journal-title":"J Med Chem"},{"key":"2019111815040899700_B10","first-page":"138","article-title":"Pharmacokinetics, safety and antitumor activity of ABT-263 in patients with relapsed or refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma.","volume":"94","author":"Wierda","year":"2009","journal-title":"Hematologica"},{"issue":"9","key":"2019111815040899700_B11","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.","volume":"68","author":"Tse","year":"2008","journal-title":"Cancer Res"},{"key":"2019111815040899700_B12","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.3542","article-title":"Reduction in platelet counts as a mechanistic biomarker and guide for adaptive dose-escalation in phase 1 studies of the Bcl-2 family inhibitor ABT-263.","volume":"26","author":"Roberts","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111815040899700_B13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.cdd.4402081","article-title":"Bcl-2 family proteins are essential for platelet survival.","volume":"14","author":"Zhang","year":"2007","journal-title":"Cell Death Differ"},{"key":"2019111815040899700_B14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","article-title":"Programmed anuclear cell death delimits platelet life span.","volume":"128","author":"Mason","year":"2007","journal-title":"Cell"},{"issue":"12","key":"2019111815040899700_B15","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1182\/blood.V93.12.4222","article-title":"Role of caspase in a subset of human platelet activation responses.","volume":"93","author":"Shcherbina","year":"1999","journal-title":"Blood"},{"issue":"4","key":"2019111815040899700_B16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2141.1997.4813284.x","article-title":"Alterations in Bcl-2\/Bax protein levels in platelets form part of an ionomycin-induced process that resembles apoptosis.","volume":"99","author":"Vanags","year":"1997","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111815040899700_B17","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1182\/blood.V94.5.1683.417k37_1683_1692","article-title":"Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation.","volume":"94","author":"Wolf","year":"1999","journal-title":"Blood"},{"key":"2019111815040899700_B18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-0502(03)00048-X","article-title":"Platelet apoptosis in stored platelet concentrates and other models.","volume":"28","author":"Leytin","year":"2003","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"2019111815040899700_B19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1537-2995.2003.t01-4-00431.x","article-title":"Apoptotic markers are increased in platelets stored at 37 degrees C.","volume":"43","author":"Bertino","year":"2003","journal-title":"Transfusion"},{"issue":"22","key":"2019111815040899700_B20","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1242\/dev.127.22.4949","article-title":"Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly.","volume":"127","author":"Wagner","year":"2000","journal-title":"Development"},{"issue":"6","key":"2019111815040899700_B21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.exphem.2010.03.003","article-title":"A novel fluorescent-based assay reveals that thrombopoietin signaling and Bcl-X(L) influence, respectively, platelet and erythrocyte lifespans.","volume":"38","author":"Coupland","year":"2010","journal-title":"Exp Hematol"},{"issue":"10","key":"2019111815040899700_B22","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1538-7836.2008.03111.x","article-title":"Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets.","volume":"6","author":"Lopez","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111815040899700_B23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/09537100903315704","article-title":"Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents.","volume":"20","author":"Lin","year":"2009","journal-title":"Platelets"},{"issue":"3","key":"2019111815040899700_B24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/blood-2009-01-200345","article-title":"Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function.","volume":"114","author":"Schoenwaelder","year":"2009","journal-title":"Blood"},{"key":"2019111815040899700_B25","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/j.1537-2995.2010.02676.x","article-title":"Platelet senescence and phosphatidylserine exposure.","volume":"50","author":"Dasgupta","year":"2010","journal-title":"Transfusion"},{"issue":"2","key":"2019111815040899700_B26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/bj3060337","article-title":"Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity.","volume":"306","author":"Morton","year":"1995","journal-title":"Biochem J"},{"issue":"1","key":"2019111815040899700_B27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma.","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"1","key":"2019111815040899700_B28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood.V75.1.116.116","article-title":"Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders.","volume":"75","author":"Kienast","year":"1990","journal-title":"Blood"},{"key":"2019111815040899700_B29","first-page":"47","article-title":"Electron microscopy methods for studying platelet structure and function.","volume":"272","author":"White","year":"2004","journal-title":"Methods Mol Biol"},{"issue":"12","key":"2019111815040899700_B30","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.","volume":"11","author":"Wilson","year":"2010","journal-title":"Lancet Oncol"},{"issue":"16","key":"2019111815040899700_B31","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1158\/1078-0432.CCR-10-0777","article-title":"Diminished sensitivity of chronic lymphocytic leukemia cells to ABT-737 and ABT-263 due to albumin binding in blood.","volume":"16","author":"Vogler","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2019111815040899700_B32","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2007-05-092684","article-title":"Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis.","volume":"111","author":"Jobe","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111815040899700_B33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1432-1033.1982.tb05898.x","article-title":"Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets.","volume":"122","author":"Bevers","year":"1982","journal-title":"Eur J Biochem"},{"issue":"1","key":"2019111815040899700_B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3260001","article-title":"Caspases: the executioners of apoptosis.","volume":"326","author":"Cohen","year":"1997","journal-title":"Biochem J"},{"issue":"2","key":"2019111815040899700_B35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.transci.2009.07.002","article-title":"The platelet storage lesion.","volume":"41","author":"Shrivastava","year":"2009","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"2019111815040899700_B36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00424-010-0859-4","article-title":"Inhibitors of Bcl-2 protein family deplete ER Ca2+ stores in pancreatic acinar cells.","volume":"460","author":"Gerasimenko","year":"2010","journal-title":"Pflugers Arch"},{"issue":"3","key":"2019111815040899700_B37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/mol.109.055830","article-title":"Dual mechanisms of sHA 14\u20131 in inducing cell death through endoplasmic reticulum and mitochondria.","volume":"76","author":"Hermanson","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"1","key":"2019111815040899700_B38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2141.1997.1572983.x","article-title":"Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods.","volume":"98","author":"Metcalfe","year":"1997","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111815040899700_B39","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1074\/jbc.275.8.5987","article-title":"Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis: a caspase-independent cell clearance program.","volume":"275","author":"Brown","year":"2000","journal-title":"J Biol Chem"},{"issue":"6","key":"2019111815040899700_B40","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI106064","article-title":"Heterogeneity of human platelets: II. Functional evidence suggestive of young and old platelets.","volume":"48","author":"Karpatkin","year":"1969","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111815040899700_B41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0037-1613245","article-title":"Collagen response and glycoprotein VI function decline progressively as canine platelets age in vivo.","volume":"88","author":"Alberio","year":"2002","journal-title":"Thromb Haemost"},{"issue":"7","key":"2019111815040899700_B42","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1158\/0008-5472.CAN-07-0082","article-title":"Targeting multiple arms of the apoptotic regulatory machinery.","volume":"67","author":"Dai","year":"2007","journal-title":"Cancer Res"},{"issue":"5","key":"2019111815040899700_B43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized.","volume":"10","author":"van Delft","year":"2006","journal-title":"Cancer Cell"},{"issue":"18","key":"2019111815040899700_B44","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/blood-2008-08-173310","article-title":"Concurrent upregulation of BCL-XL and BCL2A1 induces \u223c 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia.","volume":"113","author":"Vogler","year":"2009","journal-title":"Blood"},{"issue":"16","key":"2019111815040899700_B45","doi-asserted-by":"crossref","first-page":"13905","DOI":"10.1074\/jbc.M110.195370","article-title":"BH3-only activator proteins, Bid and Bim, are dispensable for Bak\/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets.","volume":"286","author":"Kodama","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111815040899700_B46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI28281","article-title":"Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.","volume":"117","author":"Del Gaizo Moore","year":"2007","journal-title":"J Clin Invest"},{"issue":"22","key":"2019111815040899700_B47","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1182\/blood-2010-04-280925","article-title":"Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function.","volume":"116","author":"Goodall","year":"2010","journal-title":"Blood"},{"issue":"19","key":"2019111815040899700_B48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2008-06-162958","article-title":"A HaemAtlas: characterizing gene expression in differentiated human blood cells.","volume":"113","author":"Watkins","year":"2009","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/26\/7145\/1492492\/zh802611007145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/26\/7145\/1492492\/zh802611007145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T22:44:43Z","timestamp":1637621083000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/117\/26\/7145\/104946\/BCL2BCLXL-inhibition-induces-apoptosis-disrupts"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,30]]},"references-count":48,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2011,6,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-03-344812","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,30]]}}}